The Company’s outstanding warrants as of June 30, 2026 are summarized as follows, and all were exercisable at that date.

September 2024 Warrants

On September 12, 2024, the Company entered into securities purchase agreements with four private investors with respect to the private placement of an aggregate of 51,205 shares of the Company’s common stock at a price of $16.60 per share and warrants to purchase up to an aggregate of 51,205 shares of the Company's common stock. The Company received aggregate gross cash proceeds from this private placement (exclusive of proceeds from any future exercise of the warrants) of $850,000.  The warrants have a term of two years and are exercisable at any time after September 16, 2024, at an exercise price of $16.60 per share. The warrants expire on September 11, 2026.

March 2026 Warrants

As disclosed in Note 4 - Debt, the Company issued to the Investor Warrants to purchase up to 1,291,778 shares of the Company’s common stock at an exercise price of $0.01 per share in conjunction with the issuance of the Debentures during the first quarter of 2026. The Warrants are immediately exercisable and will expire 60 months from the date of issuance. The Warrants include customary adjustment provisions for stock splits, combinations and similar events. During the second quarter of 2026, 291,778 warrants were exercised at the exercise price of $0.01 per share.